Botany, Traditional Use, Phytochemistry, Pharmacology and Quality Control of Taraxaci herba: Comprehensive Review

Author:

Wu Jianhao1ORCID,Sun Jialin1ORCID,Liu Meiqi1,Zhang Xiaozhuang1,Kong Lingyang1,Ma Lengleng1,Jiang Shan1,Liu Xiubo12,Ma Wei1

Affiliation:

1. School of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin 150006, China

2. School of Jiamusi, Heilongjiang University of Chinese Medicine, Jiamusi 154007, China

Abstract

Taraxaci herba, as a traditional Chinese medicine, is the name of the Taraxacum genus in the Asteraceae family. Documented in the Tang Herbal Medicine (Tang Dynasty, AD 657–659), its medicinal properties cover a wide range of applications such as acute mastitis, lung abscess, conjunctival congestion, sore throat, damp-heat jaundice, and vision improvement. In the Chinese Pharmacopoeia (Edition 2020), more than 40 kinds of China-patented drugs containing Taraxaci herba were recorded. This review explores the evolving scientific understanding of Taraxaci herba, covering facets of ethnopharmacology, botany, phytochemistry, pharmacology, artificial cultivation, and quality control. In particular, the chemical constituents and pharmacological research are reviewed. Taraxaci herba has been certified as a traditional medicine plant, and its flavonoids, phenolic acids, and terpenoids have been identified and separated, which include Chicoric acid, taraxasterol, Taraxasteryl acetate, Chlorogenic acid, isorhamnetin, and luteolin; they are responsible for anti-inflammatory, antioxidant, antibacterial, anti-tumor, and anti-cancer activities. These findings validate the traditional uses of Taraxaci herba and lay the groundwork for further scientific exploration. The sources used in this study include Web of Science, Pubmed, the CNKI site, classic monographs, the Chinese Pharmacopoeia, the Chinese Medicine Dictionary, and doctoral and master’s theses.

Funder

National Key Research and Development Project, Research and Demonstration of Collection, Screening, and Breeding Technology of Ginseng and other Genuine Medicinal Materials

Study on Growth and Quality Optimization of Artificial Cultivation of Bupleurum chinense

Heilongjiang Touyan Innovation Team Program

Publisher

MDPI AG

Reference172 articles.

1. Preliminary arrangement of Taraxacum plants in China;Ge;Plant Res.,1998

2. Resources of Taraxacum in China;Gong;Wild Plant Resour. China,2001

3. Shanghai Scientific and Technical Publishers (2020). Dictionary of Traditional Chinese Medicine, Jiangsu New Medical College.

4. Expression of putative luteolin biosynthesis genes and WRKY transcription factors in Taraxacum antungense kitag;Li;Plant Cell Tissue Organ Cult. (PCTOC),2021

5. Chinese Pharmacopoeia Commission (2020). Pharmacopoeia of the People’s Republic of China, China Medical Science Press.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3